| Feature | Specification |
|---|---|
| Application | 細胞シグナル伝達 |
| Protocol Time | 2h at RT |
| Sample Volume | 10 µL |
Stimulator of Interferon Genes (STING) is an adaptor protein that mediates innate immune responses to cytosolic DNA. Upon binding of cyclic dinucleotides (CDNs) produced by cGAS in response to DNA sensing, STING undergoes conformational changes and translocates from the ER to the Golgi, initiating TBK1- and IRF3-dependent induction of type I interferons and inflammatory cytokines. STING plays critical roles in antiviral defense, cancer immunosurveillance, and autoimmune pathogenesis. STING agonists are under investigation for cancer immunotherapy, aiming to boost antitumor immunity, while inhibitors are being explored for autoinflammatory and autoimmune diseases driven by excessive type I IFN signaling.
The AlphaLISA SureFire Ultra Mouse Total STING is a sandwich immunoassay for the quantitative detection of total STING in cellular lysates, using Alpha Technology.
Formats:
AlphaLISA SureFire Ultra kits are compatible with:
AlphaLISA SureFire Ultra kits can be used for:
The Total-AlphaLISA SureFire Ultra assay measures the expression level of a protein target in a cell lysate.
The Total-AlphaLISA SureFire Ultra assay uses two antibodies which recognize two different distal epitopes on the targeted protein. AlphaLISA assays require two bead types: Acceptor and Donor beads. Acceptor beads are coated with a proprietary CaptSure™ agent to specifically immobilize the assay specific antibody, labeled with a CaptSure tag. Donor beads are coated with streptavidin to capture one of the detection antibodies, which is biotinylated. In the presence of targeted protein, the two antibodies bring the Donor and Acceptor beads in close proximity whereby the singlet oxygen transfers energy to excite the Acceptor bead, allowing the generation of a luminescent Alpha signal. The amount of light emission is directly proportional to the quantity of protein present in the sample.
The two-plate protocol involves culturing and treating the cells in a 96-well plate before lysis, then transferring lysates into a 384-well OptiPlate™ plate before the addition of Total-AlphaLISA SureFire Ultra detection reagents. This protocol permits the cells viability and confluence to be monitored. In addition, lysates from a single well can be used to measure multiple targets.
Detection of Total target protein with AlphaLISA SureFire Ultra reagents can be performed in a single plate used for culturing, treatment, and lysis. No washing steps are required. This HTS designed protocol allows for miniaturization while maintaining AlphaLISA SureFire Ultra quality.
RAW 264.7 cells were seeded in a 96 well plate (60,000 cells/well) in complete medium and incubated overnight at 37°C, 5% CO2. The cells were treated with 20 µg/mL DMXAA mouse STING ligand for the indicated time points.
After treatment, the cells were lysed with 50 µL of Lysis Buffer B for 20 minutes at RT with shaking (350 rpm). STING Phospho (Ser365)* and Total levels were evaluated using respective AlphaLISA SureFire Ultra assays. For the detection step, 10 µL of cell lysate (approximately 12,000 cells) was transferred into a 384-well white OptiPlate, followed by 5 µL of Acceptor mix and incubated for 1 hour at RT. Finally, 5 µL of Donor mix was then added to each well and incubated for 1 hour at RT in the dark. The plate was read on an Envision using standard AlphaLISA settings.
As expected, DMXAA strongly induced STING phosphorylation leading to a 500-fold increase within an hour. A 2.7-fold decrease in total levels was observed around 4 hours post-treatment.
*The highly specific and sensitive Phospho STING monoclonal antibody used in this assay was developed by Cell Signaling Technology (clone D1C4T, #51865).
RAW 264.7 cells were seeded in a 96 well plate (40,000 cells/well) in complete medium and incubated overnight at 37°C, 5% CO2. The cells were treated with increasing concentrations of DMXAA mouse STING ligand for 1 hour.
After treatment, the cells were lysed with 50 µL of Lysis Buffer B for 20 minutes at RT with shaking (350 rpm). STING Phospho (Ser365) and Total levels were evaluated using respective AlphaLISA SureFire Ultra assays. For the detection step, 10 µL of cell lysate (approximately 8,000 cells) was transferred into a 384-well white OptiPlate, followed by 5 µL of Acceptor mix and incubated for 1 hour at RT. Finally, 5 µL of Donor mix was then added to each well and incubated for 1 hour at RT in the dark. The plate was read on an Envision using standard AlphaLISA settings.
As expected, DMXAA induced STING phosphorylation in a dose-dependent manner while no significant changes were observed in total levels 1 hour post-treatment.
RAW 264.7 cells were seeded in T25 flasks (2 x 106 cells/mL) in complete medium and incubated overnight at 37°C, 5% CO2. The cells were left untreated or transfected with 25 µg/mL Poly dA/dT for 6 hours.
After treatment, the cells were lysed with 1 mL of Lysis Buffer B for 20 minutes at RT with shaking (350 rpm). STING Phospho (Ser365) and Total levels were evaluated using respective AlphaLISA SureFire Ultra assays. For the detection step, 10 µL of cell lysate (approximately 40,000 cells) was transferred into a 384-well white OptiPlate, followed by 5 µL of Acceptor mix and incubated for 1 hour at RT. Finally, 5 µL of Donor mix was then added to each well and incubated for 1 hour at RT in the dark. The plate was read on an Envision using standard AlphaLISA settings.
As expected, Poly dA/dT induced STING phosphorylation leading to a 17-fold increase while total levels did not change significantly.
RAW 264.7 cells were seeded in a 96 well plate (60,000 cells/well) in complete medium and incubated overnight at 37°C, 5% CO2. The cells were treated with 100 µg/mL 2'3' cGAMP for the indicated time points.
After treatment, the cells were lysed with 50 µL of Lysis Buffer B for 20 minutes at RT with shaking (350 rpm). STING Phospho (Ser365) and Total levels were evaluated using respective AlphaLISA SureFire Ultra assays. For the detection step, 10 µL of cell lysate (approximately 12,000 cells) was transferred into a 384-well white OptiPlate, followed by 5 µL of Acceptor mix and incubated for 1 hour at RT. Finally, 5 µL of Donor mix was then added to each well and incubated for 1 hour at RT in the dark. The plate was read on an Envision using standard AlphaLISA settings.
As expected, 2'3' cGAMP triggered an increase in the levels of mouse Phospho STING peaking at 2 hours. A significant decrease in Total STING levels was observed post-phosphorylation (4- to 11-fold), likely due to its degradation.
Adherent cell lines were seeded in a 96-well plate (60,000 cells/well) and incubated overnight at 37°C, 5% CO2. Cells were lysed with 50 µL of Lysis Buffer B for 20 minutes at RT with shaking (350 rpm).
Suspension cell line (EL-4 cells) was seeded in a 96-well plate (200,000 cells/well) in HBSS + 0.1% BSA and then lysed with 100 µL of Lysis Buffer B for 10 minutes at RT with shaking (350 rpm).
STING Total levels were evaluated by AlphaLISA SureFire Ultra. For the detection step, 10 µL of cell lysate (approximately 12,000 adherent cells or 20,000 suspension cells ) was transferred into a 384-well white OptiPlate, followed by 5 µL of Acceptor mix and incubated for 1 hour at RT. Finally, 5 µL of Donor mix was then added to each well and incubated for 1 hour at RT in the dark. The plate was read on an Envision using standard AlphaLISA settings.
| Application |
Cell Signaling
|
|---|---|
| Automation Compatible |
Yes
|
| Brand |
AlphaLISA SureFire Ultra
|
| Detection Modality |
Alpha
|
| Protocol Time |
2h at RT
|
| Sample Volume |
10 µL
|
| Shipping Conditions |
Shipped in Blue Ice
|
| Target |
STING
|
| Target Class |
Phosphoproteins
|
| Target Species |
Mouse
|
| Technology |
Alpha
|
| Therapeutic Area |
Inflammation
Oncology
Virology
|
| Unit Size |
10,000 assay points
|
Are you looking for resources, click on the resource type to explore further.
The definitive guide for setting up a successful AlphaLISA SureFire Ultra assay
Several biological processes are regulated by...
We are here to answer your questions.